Yarno Wendy L
SEC-identified person · CIK 1181186 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | Director | filed 2020–2026 |
| Ideaya Biosciences, Inc. IDYA | Director | filed 2019–2026 |
| Inovio Pharmaceuticals, INC. ino | Director | filed 2017–2026 |
| Lion Biotechnologies, Inc. N/A | Director | filed 2023–2025 |
| Global Blood Therapeutics, Inc. GBT | Director | filed 2017–2022 |
| Myokardia, Inc. MYOK | Director | filed 2017–2020 |
| Alder Biopharmaceuticals INC ALDR | Director | filed 2017–2019 |
| Aratana Therapeutics, INC. PETX | Director | filed 2013–2019 |
| ST Jude Medical, LLC stj | Director | filed 2006–2017 |
| Medivation, INC. MDVN.OB | Director | filed 2013–2016 |
| Durata Therapeutics, Inc. DRTX | Director | filed 2014–2014 |
| Merck Sharp & Dohme Corp. MRK | Chief Marketing Officer | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.